APA (7th ed.) Citation

WC, Y., TY, Y., CH, Y., PCT, C., YH, H., DK, S., . . . CW, Y. (2023). Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary Fibrosis. Journal of medicinal chemistry, 66(15), 10528. https://doi.org/10.1021/acs.jmedchem.3c00644

Chicago Style (17th ed.) Citation

WC, Yu, et al. "Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary Fibrosis." Journal of Medicinal Chemistry 66, no. 15 (2023): 10528. https://doi.org/10.1021/acs.jmedchem.3c00644.

MLA (9th ed.) Citation

WC, Yu, et al. "Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary Fibrosis." Journal of Medicinal Chemistry, vol. 66, no. 15, 2023, p. 10528, https://doi.org/10.1021/acs.jmedchem.3c00644.